The DARPA ElectRx program is offering grants for research proposals to develop closed-loop neuromodulation systems targeting neural circuits in the spinal cord or peripheral nerves. These systems aim to regulate immune system functions and CNS disorders with precision and no off-target effects. The research will advance understanding of neurophysiology and technology development for minimally-invasive neural interfaces and biosensors. Proposals should focus on tailored neuromodulation treatments that adapt to individual physiology. Refer to the attached BAA for more details. Closing date for submission is Feb 25, 2015.
Opportunity ID: 270434
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-15-06 |
| Funding Opportunity Title: | Electrical Prescriptions (ElectRx) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 12, 2014 |
| Last Updated Date: | Jan 28, 2015 |
| Original Closing Date for Applications: | Feb 25, 2015 |
| Current Closing Date for Applications: | Feb 25, 2015 |
| Archive Date: | Mar 27, 2015 |
| Estimated Total Program Funding: | $50,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | The DARPA ElectRx program seeks innovative research proposals for creating closed-loop neuromodulation systems that utilize innate neurophysiological circuits to achieve therapeutic benefits. To achieve this goal, ElectRx will simultaneously drive biological understanding and technology development. Specifically, ElectRx is looking to develop and leverage fundamental understanding of the anatomy and physiology of neural circuits in the spinal cord or peripheral nerves that mediate health status. This knowledge will be leveraged to design and demonstrate feedback-controlled neuromodulation systems for the direct regulation of immune system functions and CNS disorders. In parallel, technology development focused on next-generation minimally-invasive neural interfaces and biosensors will enable interaction with the neurophysiology of interest at unmatched spatiotemporal resolution, precision, and specificity. These neuromodulation treatments will be tuned automatically and continuously to the unique physiology of each individual and will produce no off-target effects. See attached BAA for additional information. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
DARPA BAA Coordinator
Email:DARPA-BAA-15-06@darpa.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| MODIFICATION 1 – The purpose of Modification 1 to DARPA-BAA-15-06, the Electrical Prescriptions (ElectRx) Broad Agency Announcement, is to clarify the FAQ location.
DARPA will post a consolidated question and answer document (FAQ) to http://www.darpa.mil/Opportunities/Solicitations/BTO_Solicitations.aspx. Submit your question/s by E-mail to DARPA-BAA-15-06@darpa.mil. In order to receive a response, send your question/s by 13 February 2015. |
Jan 28, 2015 | |
| Jan 28, 2015 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-15-06 |
| Funding Opportunity Title: | Electrical Prescriptions (ElectRx) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 12, 2014 |
| Last Updated Date: | Jan 28, 2015 |
| Original Closing Date for Applications: | Feb 25, 2015 |
| Current Closing Date for Applications: | Feb 25, 2015 |
| Archive Date: | Mar 27, 2015 |
| Estimated Total Program Funding: | $50,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | The DARPA ElectRx program seeks innovative research proposals for creating closed-loop neuromodulation systems that utilize innate neurophysiological circuits to achieve therapeutic benefits. To achieve this goal, ElectRx will simultaneously drive biological understanding and technology development. Specifically, ElectRx is looking to develop and leverage fundamental understanding of the anatomy and physiology of neural circuits in the spinal cord or peripheral nerves that mediate health status. This knowledge will be leveraged to design and demonstrate feedback-controlled neuromodulation systems for the direct regulation of immune system functions and CNS disorders. In parallel, technology development focused on next-generation minimally-invasive neural interfaces and biosensors will enable interaction with the neurophysiology of interest at unmatched spatiotemporal resolution, precision, and specificity. These neuromodulation treatments will be tuned automatically and continuously to the unique physiology of each individual and will produce no off-target effects. See attached BAA for additional information. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
DARPA BAA Coordinator
Email:DARPA-BAA-15-06@darpa.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-15-06 |
| Funding Opportunity Title: | Electrical Prescriptions (ElectRx) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 28, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 25, 2015 |
| Archive Date: | Mar 27, 2015 |
| Estimated Total Program Funding: | $50,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | The DARPA ElectRx program seeks innovative research proposals for creating closed-loop neuromodulation systems that utilize innate neurophysiological circuits to achieve therapeutic benefits. To achieve this goal, ElectRx will simultaneously drive biological understanding and technology development. Specifically, ElectRx is looking to develop and leverage fundamental understanding of the anatomy and physiology of neural circuits in the spinal cord or peripheral nerves that mediate health status. This knowledge will be leveraged to design and demonstrate feedback-controlled neuromodulation systems for the direct regulation of immune system functions and CNS disorders. In parallel, technology development focused on next-generation minimally-invasive neural interfaces and biosensors will enable interaction with the neurophysiology of interest at unmatched spatiotemporal resolution, precision, and specificity. These neuromodulation treatments will be tuned automatically and continuously to the unique physiology of each individual and will produce no off-target effects. See attached BAA for additional information. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
DARPA BAA Coordinator
Email:DARPA-BAA-15-06@darpa.mil |
Related Documents
Folder 270434 Full Announcement-1 -> Attachment 3 – DARPA-BAA-15-06 – Budget Template.pdf
Folder 270434 Full Announcement-1 -> Attachment 2 – DARPA-BAA-15-06 – Proposal Slide Template.pdf
Folder 270434 Full Announcement-1 -> Attachment 4 – DARPA-BAA-15-06 – SOW Template.pdf
Folder 270434 Full Announcement-1 -> DARPA-BAA-15-06 – ElectRx FINAL.pdf
Folder 270434 Full Announcement-1 -> Attachment 1 – DARPA-BAA-15-06 – Proposer Checklist.pdf
Packages
| Agency Contact Information: | DARPA BAA Coordinator
Email: DARPA-BAA-15-06@darpa.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.910 | PKG00210689 | Dec 12, 2014 | Feb 25, 2015 | View |
Package 1
Mandatory forms
270434 RR_SF424_2_0-2.0.pdf
Optional forms
270434 PerformanceSite_2_0-2.0.pdf
270434 RR_OtherProjectInfo_1_3-1.3.pdf
270434 RR_KeyPersonExpanded_2_0-2.0.pdf
270434 RR_Budget10_1_3-1.3.pdf
270434 RR_SubawardBudget10_30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
